Catecholamine-Depleting Drugs: Patients receiving catecholamine-depleting drugs classes), or antiarrhythmic agents, such as disopyramide, are used
Based on the mechanism of action of iobenguane, drugs that reduce catecholamine uptake or that deplete catecholamine stores may interfere with iobenguane
Catecholamine-Depleting Drugs: Patients receiving catecholamine-depleting drugs Antiarrhythmic Agents: Bislol fumarate should be used with care when
Catecholamine-Depleting Drugs: Patients receiving catecholamine-depleting drugs classes), or antiarrhythmic agents, such as disopyramide, are used
Drugs that act as positive inotropes include the catecholamines (dobutamine and isoprenaline [synthetic catecholamines] and adrenaline and noradrenaline [
Catecholamine-Depleting Drugs: Patients receiving catecholamine-depleting drugs classes), or antiarrhythmic agents, such as disopyramide, are used
Catecholamine-Depleting Drugs: Patients receiving catecholamine-depleting drugs classes), or antiarrhythmic agents, such as disopyramide, are used
by SC Stanford 2024 Cited by 17Key drugs to emerge from catecholamine research and development. Abuse of drugs that target catecholamines. The psychotropic effects
Catecholamine-Depleting Drugs: Patients receiving catecholamine-depleting drugs inotropic effects can lead to prolongation of S-A and A-V conduction
Comments